SEC Info - Acasti Pharma Inc. - ‘40FR12G’ on 7/20/12

Acasti Pharma Inc. – ‘40FR12G’ on 7/20/12 – ‘EX-99.43’

On: Friday, 7/20/12, at 4:11pm ET · Accession #: 1171843-12-2643 · File #: 0-54771

As Of Filer Filing For·On·As Docs:Size Issuer Agent 7/20/12 Acasti Pharma Inc. 40FR12G 48:47M Globenewswire Inc./FA

Document/Exhibit Description Pages Size 1: 40FR12G Form 40-F HTML 72K 2: EX-99.1 Miscellaneous Exhibit HTML 27K 11: EX-99.10 Miscellaneous Exhibit HTML 13K 12: EX-99.11 Miscellaneous Exhibit HTML 39K 13: EX-99.12 Miscellaneous Exhibit HTML 30K 14: EX-99.13 Miscellaneous Exhibit HTML 13K 15: EX-99.14 Miscellaneous Exhibit HTML 27K 16: EX-99.15 Miscellaneous Exhibit HTML 26K 17: EX-99.16 Miscellaneous Exhibit HTML 25K 18: EX-99.17 Miscellaneous Exhibit HTML 175K 19: EX-99.18 Miscellaneous Exhibit HTML 569K 20: EX-99.19 Miscellaneous Exhibit HTML 28K 3: EX-99.2 Miscellaneous Exhibit HTML 37K 21: EX-99.20 Miscellaneous Exhibit HTML 26K 22: EX-99.21 Miscellaneous Exhibit HTML 13K 23: EX-99.22 Miscellaneous Exhibit HTML 22K 24: EX-99.23 Miscellaneous Exhibit HTML 25K 25: EX-99.24 Miscellaneous Exhibit HTML 28K 26: EX-99.25 Miscellaneous Exhibit HTML 24K 27: EX-99.26 Miscellaneous Exhibit HTML 191K 28: EX-99.27 Miscellaneous Exhibit HTML 510K 29: EX-99.28 Miscellaneous Exhibit HTML 24K 30: EX-99.29 Miscellaneous Exhibit HTML 22K 4: EX-99.3 Miscellaneous Exhibit HTML 55K 31: EX-99.30 Miscellaneous Exhibit HTML 23K 32: EX-99.31 Miscellaneous Exhibit HTML 178K 33: EX-99.32 Miscellaneous Exhibit HTML 528K 34: EX-99.33 Miscellaneous Exhibit HTML 25K 35: EX-99.34 Miscellaneous Exhibit HTML 24K 36: EX-99.35 Miscellaneous Exhibit HTML 24K 37: EX-99.36 Miscellaneous Exhibit HTML 13K 38: EX-99.37 Miscellaneous Exhibit HTML 24K 39: EX-99.38 Miscellaneous Exhibit HTML 12K 40: EX-99.39 Miscellaneous Exhibit HTML 22K 5: EX-99.4 Miscellaneous Exhibit HTML 25K 41: EX-99.40 Miscellaneous Exhibit HTML 23K 42: EX-99.41 Miscellaneous Exhibit HTML 749K 43: EX-99.42 Miscellaneous Exhibit HTML 31K 44: EX-99.43 Miscellaneous Exhibit HTML 19K 45: EX-99.44 Miscellaneous Exhibit HTML 234K 46: EX-99.45 Miscellaneous Exhibit HTML 13K 47: EX-99.46 Miscellaneous Exhibit HTML 23K 48: EX-99.47 Miscellaneous Exhibit HTML 15K 6: EX-99.5 Miscellaneous Exhibit HTML 30K 7: EX-99.6 Miscellaneous Exhibit HTML 16K 8: EX-99.7 Miscellaneous Exhibit HTML 12K 9: EX-99.8 Miscellaneous Exhibit HTML 19K 10: EX-99.9 Miscellaneous Exhibit HTML 27K

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

TAKE NOTICE that the Annual and Special Meeting of the Shareholders (the “Meeting”) of Acasti Pharma Inc. (the “Corporation”) will be held at Hilton Garden Inn Montréal Centre-Ville Hotel, 380 Sherbrooke Street West, Charles de Bleury Room, Montréal (Québec), on June 21, 2011 at 10:00 am, for the following purposes:

1.	To receive the financial statements of the Corporation for the financial year ended February 29, 2012 and the auditors' report thereon;

2.	To elect the directors of the Corporation for the ensuing year;

3.	To appoint the auditors for the ensuing year and to authorize the directors to fix their remuneration;

4.	To consider and, if deemed appropriate, to adopt a special resolution (the text of which is reproduced in the accompanying Management Proxy Circular) ratifying the resolution

5.	To consider and, if deemed appropriate, to adopt a resolution (the full text of which is reproduced in the accompanying Managemen Proxy Circular) ratifying the resolution

6.	To transact such other business as may properly be brought before the Meeting or any adjournment thereof.

Shareholders may exercise their rights by attending the Meeting or by completing a form of proxy. The directors have established May 15, 2012 as the record date for the purpose of determining the Corporation’s shareholders which are entitled to receive notice of and to vote at the Meeting. Should you be unable to attend the Meeting in person, please complete, date and sign the enclosed form of proxy and return it in the envelope provided for that purpose. Proxies must be received by the transfer agent and registrar of the Corporation, Computershare Investor Services Inc. (Attention: Proxy Department), 100 University Avenue, 9th Floor, Toronto, Ontario, Canada, M5J 2Y1, no less than 48 hours (excluding Saturdays, Sundays and holidays) prior to the day of the Meeting. Your shares will be voted in accordance with your instructions as indicated on the form of proxy, or failing instructions, in the manner set forth in the accompanying Management Proxy Circular.

SIGNED IN LAVAL, QUÉBEC, AS OF MAY 25, 2012

BY ORDER OF THE BOARD OF DIRECTORS

/s/ Ronald Denis

_______________________________________________

Dr. Ronald Denis

Chairman of the Board

This ‘40FR12G’ Filing

Date

Other Filings

Filed on:

7/20/12

F-X

5/25/12

5/15/12

2/29/12

6/21/11

List all Filings

Acasti Pharma Inc. – ‘40FR12G’ on 7/20/12 – ‘EX-99.43’

On: Friday, 7/20/12, at 4:11pm ET · Accession #: 1171843-12-2643 · File #: 0-54771

Previous ‘40FR12G’: None · Next & Latest: ‘40FR12G/A’ on 7/24/12

Registration of Securities of a Canadian Issuer — SEA’34 §12(g) — Form 40-F
Filing Table of Contents

EX-99.43 — Miscellaneous Exhibit

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Acasti Pharma Inc. – ‘40FR12G’ on 7/20/12 – ‘EX-99.43’

On: Friday, 7/20/12, at 4:11pm ET · Accession #: 1171843-12-2643 · File #: 0-54771

Previous ‘40FR12G’: None · Next & Latest: ‘40FR12G/A’ on 7/24/12

Registration of Securities of a Canadian Issuer — SEA’34 §12(g) — Form 40-FFiling Table of Contents

EX-99.43 — Miscellaneous Exhibit

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Registration of Securities of a Canadian Issuer — SEA’34 §12(g) — Form 40-F
Filing Table of Contents